The modular laser system consists of a universal console with high-power laser diode, a microcomputer, power supply, cooling system, touch screen and optical and electrical ports for connection to the clinical module of application; as well as various clinical applications modules that can be attached to the console and activated after configuring the software and user interface. Replacement of the module may be performed by a doctor yourself.

StLase - the first module is designed for soft tissue surgery. The use of a laser system fundamentally new technology thermo surgery TOP ™ allows you to create a new standard of laser surgery. More details. Made the first batch of a universal console with integrated stLase for demonstration, training doctors and first sale.

 

News

Watch an interactive report by RIA Novosti about the exhibits at the exhibition "Open Innovations Expo". Click the player buttons to learn about StLase modular laser system and other technological innovations.
 

 

The company Photonics, invested by Maxwell Biotech Venture Fund and RVC Seed Fund, has received minigrant of Skolkovo Foundation in the amount of 5 million rubles for initial proof of principle of a concept of gingival and aveolar bone regeneration using a new method of oral tissue treatment with LPM technology, which will be implemented in a new dental laser for hard tissue surgery by Photonics.

The company Photonics, invested by Maxwell Biotech Venture Fund and RVC Seed Fund, has received minigrant of Skolkovo Foundation in the amount of 5 million rubles for initial proof of principle of a concept of gingival and aveolar bone regeneration using a new method of oral tissue treatment with LPM technology, which will be implemented in a new dental laser for hard tissue surgery by Photonics.

Photonics, Ltd. is an innovative private company founded in 2010 that has been developing and launching into the domestic market novel medical laser systems for soft (stLase) and hard (atLase) tissues surgery. The project development is carried out in close collaboration with the American partner, Dental Photonics Inc.

Dmitry Popov, managing partner at Maxwell Biotech Venture Fund: "The success of the research activities planned by Photonics will not just speed up manufacturing of the medical prototype of a new device, but will also provide the company with a strong marketing position in the future".

StLase system (known to the global market under the brand name Alta®) is the first multifunction platform for laser dentistry. This compact laser device consists of a main console, equipped with a 7-inch interactive touch screen, and applicable modules for various procedures and treatment methods that are attached to the side of the console. Advantage of the new laser systems are their compactness, multi-functionality, ergonomics, and relatively low cost. In addition to the dental treatment the laser system can also be used in cardiovascular surgery, surgery in obstetrics and gynecology, ENT, proctology and other fields of medicine.

In 2012 Photonics completed registration procedures of its first laser device in Russia and held a number of marketing activities, which allowed it to begin selling innovative laser system stLase in Russia in early 2013.

In January 2013 Photonics, with investments from Maxwell Biotech Venture Fund and RVC Seed Fund, made ​​the first domestic sale of the laser system stLase known to the global market under the brand name Alta®. The company's development partner, Dental Photonics Inc., is engaged in the commercialization of the product in the global market and has placed over a dozen laser systems beginning in March 2012 in the United States and in Japan as of July 2012.  They also plan on selling in South Korea upon approval from the local regulator (KFDA).

In January 2013 Photonics, with investments from Maxwell Biotech Venture Fund and RVC Seed Fund, made ​​the first domestic sale of the laser system stLase known to the global market under the brand name Alta®. The company's development partner, Dental Photonics Inc., is engaged in the commercialization of the product in the global market and has placed over a dozen laser systems beginning in March 2012 in the United States and in Japan as of July 2012.  They also plan on selling in South Korea upon approval from the local regulator (KFDA).

"Photonics recent sales are very important news for our fund. StLase has become the first world-class innovative product developed with the participation of Maxwell Biotech Venture Fund, to enter both global and the Russian markets and is already being used to treat patients in the United States, Russia and Japan. We are confident that through the coordinated efforts of our international team that successfully completed the development and sale preparation of stLase, this device will hold a strong position in the competitive market of dental laser equipment,” said Dmitry Popov, Managing Partner of Maxwell Biotech Venture Fund.

"We are excited about commencement of commercial sales in the Russian Federation. This laser system features best-in class medical technology created over several years of intense collaboration with our Russian partners. The product’s unprecedented precision, speed, safety and ease of use have been enthusiastically received by top key opinion leaders in the U.S. We are pleased with the continued adoption of our products by top Russian clinicians and look forward to working with our international partners to establish a leading position in the medical laser instruments market,” said Alexander Vybornov, Dental Photonics’ CEO.

Alexey Teleshev, CEO of RVC Seed Fund added: "Photonics is a unique illustration of the global competitiveness of Russian technologies, developed in partnership with international experts. At the moment, the project has reached a major milestone and has started generating revenue as a result of the first sales in Russia and abroad."

StLase (Alta®) — is a compact laser system designed for various procedures and treatments on the soft tissues. The system consists of the main console, equipped with a 7-inch interactive touch screen, and the applicable modules that can be attached to the side of the console. Advantages of the new laser system include its compactness, multi-function capabilities, ergonomics, and the relatively low cost. The device can also be used in cardiovascular surgery, surgery in obstetrics and gynecology, ENT, proctology as well as other medical fields.

In late 2012, the developed design won two prestigious international awards: iF Product Design Award in 2013 and 2012 Good DesignTM.

In December 2012 the modular laser system stLase (represented in the global market under the brand name Alta®) developed within close partnership between Photonics, a portfolio company of Maxwell Biotech Venture Fund and RVC Seed Fund, and the US company Dental Photonics Inc. won a prestigious 2012 GOOD DESIGN™ Award in the nomination Medical 2012. This is the second prestigious international award in the field of design won by the laser system stLase in late 2012. The first was the iF Product Design Award 2013, which was previously reported.

In December 2012 the modular laser system stLase (represented in the global market under the brand name Alta®) developed within close partnership between Photonics, a portfolio company of Maxwell Biotech Venture Fund and RVC Seed Fund, and the US company Dental Photonics Inc. won a prestigious 2012 GOOD DESIGN™ Award in the nomination Medical 2012. This is the second prestigious international award in the field of design won by the laser system stLase in late 2012. The first was the iF Product Design Award 2013, which was previously reported.

“We are excited about the continuing recognition of the best-in-class design and superior quality,” remarked Alexander Vybornov, Dental Photonics Chief Executive Officer.  “Building upon the years of research and development, the Alta® MLS is the first dental laser platform with no obsolescence that offers distinct advantages in speed, safety and ease of use.”

Founded in 1950 and managed by the Chicago Athenaeum: Museum of Architecture and Design and The European Centre for Architecture Art Design and Urban Studies, GOOD DESIGN remains the oldest and the world's most recognized program  for design excellence worldwide. For 2012, the Museum received submissions from several thousand of the world's leading manufacturers and industrial and graphic design firms from over 48 countries. In November 2012, the jury met in New York and selected over 700 product designs and graphics from over 38 nations worthy of the GOOD DESIGN Award for their Design Excellence. stLase (Alta® MLS) became one of the 27 winners in Medical 2012.     

stLase (Alta® MLS) is the first compact modular laser device that allows for the integration of the targeted dental lasers intended for a wide range of treatment modalities.  It is  comprised of an upgradable central console and application-specific modules that can be easily and quickly attached to the side of the unit.  The system is lightweight, portable, and can be placed on a table top or mounted on a wall for the ultimate flexibility required in any dental surgery setting.  A 7” interactive touch screen allows for intuitive device navigation and easy viewing from multiple angles and distances. 

In 2012, Photonics completed registration procedures in Russia and held a number of marketing activities, which will allow the company to begin selling innovative laser system in Russia in early 2013.

Technology Update by Russia Today features Photonics invested by Maxwell Biotech Venture Fund and RVC Seed Fund in its latest episode "Medical marvels" of Dec 28th, 2012.

Technology Update by Russia Today features Photonics invested by Maxwell Biotech Venture Fund and RVC Seed Fund in its latest episode "Medical marvels" of Dec 28th, 2012.

See more at rt.com

The modular laser system stLase (represented in the global market under the brand name Alta ®), developed by Photonics, invested by Maxwell Biotech Venture Fund and RVC Seed Fund, together with U.S. partner company Dental Photonics Inc, has won a prestigious 2013 iF Product Design Award.

The modular laser system stLase (represented in the global market under the brand name Alta ®), developed by Photonics, invested by Maxwell Biotech Venture Fund and RVC Seed Fund, together with U.S. partner company Dental Photonics Inc, has won a prestigious 2013 iF Product Design Award.

Building upon the years of research and development, stLase is the first dental laser platform with no obsolescence. This compact modular laser device allows for the integration of the targeted dental lasers intended for a wide range of treatment modalities. It is comprised of an upgradable central console and application-specific modules that can be easily and quickly attached to the side of the unit. The system is lightweight, portable, and can be placed on a table top or mounted on a wall for the ultimate flexibility required in any dental surgery setting. A 7” interactive touch screen allows for intuitive device navigation and easy viewing from multiple angles and distances.

For 60 years, the iF award remains an internationally recognized symbol for the best-in-class design. Sponsored by the International Forum Design GmbH in Hanover, Germany, the 2013 iF design competition received 3,011 entries. A world renowned jury evaluated the submissions utilizing 11 criteria including design quality, degree of innovation, ergonomics and functionality.

“We are honored to win this coveted design award,” remarked Alexander Vybornov, Dental Photonics Chief Executive Officer. “The award recognizes Alta® MLS for its superior quality, versatility, functional design and ease of use. We are thrilled to bring to market this next-generation laser system that combines a cutting-edge technology with a best-in-class product design.”

In 2012, Photonics completed registration procedures in Russia and held a number of marketing activities, which will allow the company to begin selling innovative laser system in Russia in early 2013.

 

This month innovators, financiers and government reps got together to spur growth and change at the first-ever Open Innovations Forum. Thousands of high-tech goodies were on display.

Russia Today, Technology Update, December 5th, 2012

This month innovators, financiers and government reps got together to spur growth and change at the first-ever Open Innovations Forum. Thousands of high-tech goodies were on display.

Russia Today, Technology Update, December 5th, 2012

The International Dental Exhibition named "MosExpoDental”, which will coincide with the 10th CIS Dental Congress, will be held from 14th to 17th November, 2012, in the Moscow Gostiny Dvor. The first day of the Dental Congress, November 14, will comprise the International Symposium "Innovations in dentistry in the CIS countries and the world".

The International Dental Exhibition named "MosExpoDental”, which will coincide with the 10th CIS Dental Congress, will be held from 14th to 17th November, 2012, in the Moscow Gostiny Dvor. The first day of the Dental Congress, November 14, will comprise the International Symposium "Innovations in dentistry in the CIS countries and the world". The symposium will feature Professor Igor Shugailov, Chief Medical Adviosor of Photonics, who will give a lecture on the latest technology developments implemented in stLase and atLase surgical laser systems, and the benefits they deliver to doctors and patients.

Photonics LLC, a portfolio company of RVC Seed Fund and Maxwell Biotech Venture Fund, both backed by JSC "RVC", has recently presented stLase - its innovative medical laser system for soft tissue surgery – at the Moscow International Innovation Forum "Open Innovation". This week, the device will be presented to the attendees of "MosExpoDental” in the booth of Photonic’s partner, OOO IT-Stom.

An innovative medical laser system stLase for soft tissue surgery was exhibited and presented by Photonics Ltd. at the Moscow International Forum of Innovative Development "Open Innovation", held from October 31 to November 3, 2012. Photonics Ltd is a portfolio company of RVC Seed Fund and Maxwell Biotech Venture Fund, both established with the participation of JSC RVC capital.

An innovative medical laser system stLase for soft tissue surgery was exhibited and presented by Photonics Ltd. at the Moscow International Forum of Innovative Development "Open Innovation", held from October 31 to November 3, 2012. Photonics Ltd is a portfolio company of RVC Seed Fund and Maxwell Biotech Venture Fund, both established with the participation of JSC RVC capital.

The Innovative medical laser systems stLase for soft tissue surgery is designed for surgical interventions in dentistry, and prospectively, in the cardiovascular surgery, gynecology, ENT, proctology and other areas of medicine.

At Skolkovo booth, visitors could learn about the history of technology applied in stLase, and see the industrial and engineering prototypes, as well as the laboratory prototype of the laser system. Another industrial prototype was exhibited in the RVC area. Guests of the forum had an opportunity to witnessthe main advantages of the device: it’s compact size, multiple functionality and ergonomics. New technology incorporated in stLase, enable real-time computer monitoring and control of the incision quality and patient’s safety.

 

Photo: Felix Feldstein (left) Photonics' scientific advisor at Skolkovo booth.

"In the Morning", NTV, October 23, 2012

"In the Morning", NTV, October 23, 2012

The International Congress "Laser dentistry and facial aesthetics", dedicated to the latest trends and problems of laser dentistry was held in the exhibition center "Crocus Expo", Moscow, on September 18, 2012. The Congress was organized by the Russian Dental Association, The Russian Association of Laser Dentistry and exhibition company DentalExpo in conjunction with the leading universities, research institutes and industrial companies in the United States and Russia.

The International Congress "Laser dentistry and facial aesthetics", dedicated to the latest trends and problems of laser dentistry was held in the exhibition center "Crocus Expo", Moscow, on September 18, 2012. The Congress was organized by the Russian Dental Association, The Russian Association of Laser Dentistry and exhibition company DentalExpo in conjunction with the leading universities, research institutes and industrial companies in the United States and Russia.

The Congress brought together the leading laser dentistry experts from Russia and the United States, who elaborated on the technical and medical aspects of laser use. The panels included many strong professionals - the modern dental elite of Russia, representatives of the leading hospitals, practitioners, members of scientific organizations and academics, which was very helpful for an active and interesting discussion.

The top Congress speaker was Gregory Altschuler, a leading laser dentistry specialist from the U.S., Palomar senior vice president, DPI-Photonics scientific director and "Photonics" chief scientific advisor. He highlighted theoretical, medical and technical aspects of development and application of the laser technology in dentistry and aesthetic medicine.

According to Professor Shugailov, Chairman of the "Association of Laser Dentistry" Panel of the Russian Dental Association (RDA), Head of Dentistry Department at the Academy of Postgraduate Medical Education, the Congress has shown the strong interest to new technologies in Russia, and provided answers to the many dentists’ questions that arise when they implement advanced dental technologies in practice. Considerable specialist interest to laser technology is associated with the fact that the laser can be used in minimally invasive and painful treatment, which is the key trend in dentistry of the XXI century.

Professor Shugailov also expressed special thanks to the Russian Venture Company - the main sponsor of the congress, which had supported the event as part of its program to stimulate demand for the product of innovative companies - and "Photonics" - the general partner of the event, a portfolio company of Maxwell Biotech Venture Fund and RVC Seed Fund. OOO "Photonics" is engaged in development and local marketing of the new medical laser systems for soft (stLase) and hard (atLase) tissue surgery.

The Congress turned out to be a significant scientific, practical and educational event for the Russian dentistry. It confirmed the interest of local dentists to advanced technologies and treatments and can provide another impetus to the development of laser dentistry in Russia.

On the 18th of September, 2012, The Russian Dental Association, The Russian Association of Laser Dentistry and exhibition company DentalExpo jointly with the leading universities, research institutes and industrial companies in the United States and Russia will hold the International Congress "Laser dentistry and facial aesthetics."

On the 18th of September, 2012, The Russian Dental Association, The Russian Association of Laser Dentistry and exhibition company DentalExpo jointly with the leading universities, research institutes and industrial companies in the United States and Russia will hold the International Congress "Laser dentistry and facial aesthetics."

JSC "RVC” is the general sponsor of the event,  The general partner of the Congress is the private innovation company "Photonics", which is engaged in development and local marketing of the new medical laser systems for soft (stLase) and hard (atLase) tissue surgery. "Photonics" has received financing from Maxwell Biotech Venture Fund and RVC Seed Fund, established by RVC as a founding member, and has gained residency in the Skolkovo innovation centre.

The constantly growing involvement of advanced laser technology in dental medicine is one of the key trends in modern dentistry. Specialized lasers gradually become routine and almost indispensable device for the modern dental practice. However, there is still considerable "lack of awareness" among specialists associated not only with technical and medical nuances of laser applications, but also with organizational and legal aspects of laser systems implementation in medical practice. The upcoming "Laser Congress" is intended to fill this gap by summarizing the international and local experience in the application of laser systems, by informing on the latest research breakthroughs and developments and by enlightment on many organizational and legal issues concerning the Russian dentists. Professional associations, academic institutions, the leading global educators, practitioners, developers and manufacturers have pooled their effort to to address this challenge.

Numerous organizations were involved in the preparation of the Congress: Dental Association of Russia (StAR), Russian Association of Laser Dentistry, DentalExpo exhibition company, Academy of Postgraduate Medical Education RMAPO. Russian and foreign universities also took part, including MSMSU, Central Research Institute of Dental and Maxillofacial Surgery, Prokhorov Institute of General Physics of Russian Academy of Science, New York University (USA). Мanufacturers of laser equipment - Biolase (USA), Palomar (USA), DPI-Photonics (USA), ООО "Lakhta Milon", ООО "Rada-Pharma,"  "Intelstom", ООО "ITStom" etc – expressed their strong interest in participating the project.

This is the second international congress on laser dentistry, which is held in Russia (the first was organized as a section of the old "Laser Dentistry Association," International Association of Laser Dentistry SOLA and the Institute of General Physics. Prokhorov, Russian Academy of Sciences in 2010), indicating an increase of the role of Russia the international medical arena and the huge interest in laser technology from the Russian of dentists.

This is the second international congress on laser dentistry, which is held in Russia (the first one was organized in 2010 by "Laser Dentistry Association," International Association of Laser Dentistry SOLA and the , Prokhorov Institute of General Physics of Russian Academy of Science). This indicates Russia’s growing influence in the international medicine and huge interest in laser technology expressed by the Russian dentists.

The Congress agenda includes speeches by the leading foreign and local experts, which will cover  the most pressing issues of modern dentistry related to laser technology: implant and periodontal intervention, endodontics, soft tissue surgery, preparation of dental hard tissue, photoactivated disinfection, photodynamic treatment of inflammatory diseases, and discoloration of dental hard tissues, marketing issues in practices using laser technology, and other topics.

Special attention will be paid to the aesthetic restorative operations. Speakers will cover such issues as the use of innovative laser technology for the treatment of dental disease and restoration of facial aesthetics and the first Impressions from the use of the last generation multifunctional laser equipment, its prospective use for intervention on the hard and soft tissues in oral and maxillofacial surgery.

 The Congress will be a noteworthy event including scientific, practical and educational activities which will boost development of laser dentistry in Russia and highlight many issues questioned by numerous users of dental laser systems.

MIR • July 26, 2012 138 0

One of the most common fears of the modern person is a visit to the dentist’s office. Dental drilling machine, pain, skyrocketing prices. Today all these fears are treated with new technologies. Photonics is engaged in design and introduction to the domestic market of fundamentally new medical laser systems for soft and hard tissue surgery.

MIR • July 26, 2012 138 0

One of the most common fears of the modern person is a visit to the dentist’s office. Dental drilling machine, pain, skyrocketing prices. Today all these fears are treated with new technologies. Photonics is engaged in design and introduction to the domestic market of fundamentally new medical laser systems for soft and hard tissue surgery.

The correspondent of MIR (Young Innovative Russia) site met with Igor Shugailov, Chief Medical Advisor of the Skolkovo resident company (biomedical technologies cluster), President of Laser Stomatology Association of Russia, and Anna Zelenkova, PR-Director.

What was happening in the area of laser equipment before new technologies have appeared?

Igor Shugailov: The way everybody was following earlier is perceived as a dead end now. You see, a certain technological limit has been reached. In particular, until recently hydrokinetic dentistry lasers have been applied, in the first turn, for odontotrypy to replace dental drilling machines. That is why, for a long time there was racing for maximum power. High-power lasers were created. With great disadvantages, as we can understand now. First, they are awfully bulky and costly. Second, they require very delicate maintenance. In case of any defects or faults, they require a qualified specialist and considerable expenses. All that has led to the fact that only a small number of clinics have the possibility to operate such devices.

And diode lasers are cheaper, they are more reliable. So far they are limited only to soft tissue surgery. But it’s only a temporary limitation.

What is the main advantage of the new technology?

Igor Shugailov: When laser radiation leaves the fiber tip, then sole optical power with the help of which tissue can be cut is not enough, as the depth of diode laser penetration is great: 1 to 1.5 mm and more. That is why, all that power is dispersed in tissue. In addition, tissue can be heated up intensely but not cut. But when we touch the tissue, then there occurs the fiber tip carbonization. This process is called fiber tip initialization. The optical power flow cannot leave the fiber any more, it is concentrated on this carbon film, and then the tip incandesces. Thus, it can be initialized in tissues but, since it became clear, the initialization has been done before the operation. One takes a burnt cork or mat-surface black paper, touches it with the fiber tip, switches on laser, an even carbon film covers the fiber tip and it incandesces. And this is here that thermal power starts working.

What is the problem of the method?

Igor Shugailov: Well, when you cut tissues with laser, a laser scalpel – incandesced fiber tip – meets various tissue types on its way. Among them are fibrous tissues, muscular and fatty tissues, blood vessels. Each tissue type has its coefficient of power adsorption. Therefore, even if the laser scalpel moves smoothly, it turns out that in one point the tissue is “underburnt”, in another  “overburnt”. Besides, it is impossible to insert scalpel absolutely evenly! A surgeon is not a robot. It results in uneven incision depth. On the second thought, it is a serious trauma for an organism. Despite that, laser treatment wounds are healed faster, postoperative pains and postoperative edema are significantly less.

All diode lasers in the world operate by the same principle. In fact, it is an incandesced fiber tip. They differ only in design, output power, wavelength and some other parameters. The rest is all the same. That's exactly why the new generation of diode lasers has been created, namely, the universal stLase platform, with the help of which operations can be made on soft tissues, by excluding all those drawbacks connected with uncontrolled tissue coagulation.

What is the area of stLase application?

Igor Shugailov: Its application is primarily planned for dentistry, in particular, for operations in maxillofacilal area and for a number of other diagnostic and treatment procedures. For example, for treatment of periodontitis the majority of the adult population of the planet suffers from. With such disease, the organism starts rejecting own tissues that may lead to teeth loss. The reason for it is poor oral hygiene, congenital disturbance of occlusion or its disturbance as a result of poor quality dental prostheses – crowns or fillings.

StLase, like other diode lasers, is also applicable for any other operative interventions: among them is general surgery, as well as urology, cosmetology, and ENT-surgery. Qualitative indicators of such lasers increase constantly. For the last 5–7 years, there was a great progression in this area. No exhibition in Russia, Europe or USA is held without new modification of the devices.

StLase implements a new technology: initialization of the fiber tip with the help of nanocarbonization. A thin even nanocarbon film is applied under the computer control. Nanocarbonization of the tip fulfills two functions: 

1. Heats up the fiber tip and converts from wavelength of 970 Nm, which goes rather deeply into the tissue, to radiation from 4,000 to 11,000 Nm, which is absorbed by water in panniculus. As a result, all converted optical power is absorbed by panniculus. Besides, the surgeon has tactile link with the scalpel and incision speed is not less than the one of СО2 laser.

2. stLase ensures feedback, that is, laser cuts and at the same time analyses and maintains the preset temperature in the operative field. Thus, on the laser display, we set up not power but temperature in tissues, being optimal for such operation. It provides for reduction in operative intervention injury potential. High precision and speed of incisions ensure all the positive effects for the patient.

In the near future, an attachment will be introduced to stLase, which will convert it into erbium laser that will enable the dentist to make operations on hard tooth tissues, maxillary bones and mineralized dental deposits. Such upgrade will be available to every stLase owner, as it will not involve changes in the patient reception technology, existing in a given dentist’s office: the attachment does not alter the laser dimensions, and low-level cost will promote wide and fast practical application.

Who holds the palm of victory in the area of laser equipment development now?

Igor Shugailov: Cut-edging design efforts are made by our physicists. If you take a Western company dealing with laser medicine, be sure that our physicists work there. An example is not far to seek. So, the author of the thermo-optical surgery used in stLase, Gregory Altshuler is Senior Vice-President for science and technology of one of the largest American companies in the sphere of laser medicine – Palomar. He is a LITMO graduate, the author of about a hundred of patents. Thanks to him, the world laser medicine has made a groundbreaking breakthrough. The Vice-President of the American company, BioLase, the largest in the world in hydrokinetic dentistry laser sales volumes, is also a Soviet scientist – Dmitry Butusov. There are a lot of similar examples. 

How has the company received its first investments and what comprises its joint work with Skolkovo?

Anna Zelenkova: Photonics joined the project for laser design at the stage when only the first prototype of stLase system had been developed. The project attracted investments of Maxwell Biotech Venture Fund, an RVC portfolio fund, and RVC Seed Fund. Expert commissions of these two funds saw the technology potential and were the first to invest into the design. After that the company became a resident of Skolkovo Fund and applied for a grant for designing the next model of the device for work with hard tissues.

Are there specialists in Russia to operate such devices?

Igor Shugailov: There are specialists of such level but not many of them – engineers, physicists. As for dentists, it is planned to train them to operate the device. Retraining everybody is a very long process. It is necessary to create remote training methods: video films, clips, trainings for doctors to learn to master the device independently. And when take the exams in person.

What is the case with serial production?

Igor Shugailov: In future, it is planned to tailor production of stLase in Russia. From the point of view of cost, it is more profitable. It is complicated for Western companies to compete with the Russian producers of diode lasers in the Russian market. Some of our producers give a warranty period for their equipment up to 60 months! An enormous period. Our fiber is of the same quality but costs considerably lower. Unfortunately, people have still preserved prejudice to the Russian medical equipment. But it will be overcome.

In your opinion, how will this technological line develop further?

Igor Shugailov: I think, and my colleagues will agree with me that modern dentistry must restore not only beauty and high functionality of the dentition but make reconstruction of face aesthetics in general. I would like to say that dentists should be given an opportunity to perform procedures, enabling complex rehabilitation of patients.

If a dental clinic uses laser equipment, it should not limit itself only to teeth. The dentist must have a possibility, as an example, for eradicating lines that have been formed in the patient’s face as a result of disturbance of occlusion. It is for the benefit of both the patient and the doctor. By the way, modern dentist equipment, such as stLase, allows doing it. This concept will be outspoken at the forthcoming congress on September 18 to be held in Moscow. A medical aesthetics course for dentists already exists in the New-York University. It is necessary to develop a new standard of work for the Russian dentists as well. 

Does the experience of foreign colleagues you meet help you in any way?

Igor Shugailov: There can’t be excessive experience. Recently, a review was published of an American author who analyzed several thousand publications of international specialists. The subject of the analysis were results of laser application at periodontitis treatment. The following conclusion has been made: actually there are no proven advantages of laser application during treatment that would be confirmed by evidence-based medicine. It is clear that this is a biased article but it is not less interesting. Doctors who have knowledge and experience in application of laser technologies in treatment of such disease, know well that it is not the case! But specialists who do not know well or do not have work experience in laser dentistry are brought to a nonplus by such research. In fact, the number of publications based on objective criteria prove high efficiency and safety of application of laser technologies in dentistry is just not large. 

And if there are only few fair publications, as you say, then how do you exchange experience with your colleagues?

Igor Shugailov: We organize congresses. When there is a visible result. We succeed in holding these events only as often as once in 2 years. On September 18, for example, we are holding a congress jointly with the Americans and will show what was before and what we have today. And also what a specialist can expect in the sphere of application of laser technologies in diagnostics and treatment of dental diseases in the nearest future.

The first laser was created in the Soviet Union in 1960 by Soviet scientists, Alexander Prokhorov and Nikolay Basov. Dentists and cardiac surgeons were the first to apply it in practical medicine. The author of thermo-optical surgery implemented with the help of equipment of Photonics is Gregory Altshuler

Specially for MIR site.

Photonics, Ltd. invested by Maxwell Biotech Venture Fund and by RVC Seed Fund, supported by OJSC RVC, received registration certificate for its first device – laser module stLase for soft tissues surgery from Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation.

Photonics, Ltd. invested by Maxwell Biotech Venture Fund and by RVC Seed Fund, supported by OJSC RVC, received registration certificate for its first device – laser module stLase for soft tissues surgery from Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation.

Photonics is a private innovation company established in 2010. The Company is engaged in the development and introduction into the domestic market of new medical laser systems for soft (stLase) and hard (atLase) tissues surgery. New laser systems advantages are their compatibility, multifunctionality, usability as well as their relatively low costs. StLase core application area is dentistry; however, the device may be applied in non-contact cardiovascular surgery, surgical interference in obstetrics and gynecology, otolaryngology,   proctology, and other medical spheres.

Preclinical and clinical trials of stLase was conducted last year demonstrated a possibility of key technologies realization and proved the effect of tissues coagulation. This effect was reached through the application of laser induced infrared rays and laser power automatic control, which made it possible to perform surgery of soft tissues at a new level of effectiveness and safety. Moreover, a new thermo-acousto optic effect of stLase was discovered, which may be applied in dentistry for scaling through shock wave generation and cavitating.

For the time being, a pilot lot of 5 devices has been produced and a plan for stLase launch into the Russian market has been developed. One of the devices has been already installed in Dental Care Clinic No.49 of Health Care Department of the city of Moscow.

Dmitry Popov, managing partner of Maxwell Biotech Venture Fund: “We are very glad that our fund investments have resulted into the appearance in the Russian market of an innovative laser system with unique technological characteristics, which is able to solve many medical issues”.

Alexei Teleshev, the Director of RVC Seed Fund: “Laser systems are used in dentistry in many countries. In the future they are likely to be widely popular in the Russian dentistry, particularly in surgery. Medical projects have always been and still remain one of the most challenging. These projects have to overcome a lot of hindrances starting from the very idea to its realization and introduction to the market. Photonics has gone through these hindrances quite successfully and we will be glad to support it in future”.

Igor Shugailov, doctor of medical science, professor, the Head of Dentistry Department of Russian Medical Academy of Postgraduate Education of Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation, the chairman of Russian Laser Dentistry Association: “When doing clinical trials of stLase, the leading dentists of Russia and the USA have already made sure  that this device has certain advantages. Its introduction into the everyday practice will enable doctors to improve the quality of surgical interventions in dentistry”.

 

Last week, on April 17-20, Photonics, Ltd. financed by Maxwell Biotech Venture Fund, created with the participation of RVC, and RVC Seed Fund, took part in laser equipment fair “PHOTONICA. The world of laser and optics – 2012”. The Company presented stLase, an innovative laser system designated for soft tissues surgery. The showpiece presented at the Company’s stand was one of 5 devices produced at the beginning of 2012.

Last week, on April 17-20, Photonics, Ltd. financed by Maxwell Biotech Venture Fund, created with the participation of RVC, and RVC Seed Fund, took part in laser equipment fair “PHOTONICA. The world of laser and optics – 2012”. The Company presented stLase, an innovative laser system designated for soft tissues surgery. The showpiece presented at the Company’s stand was one of 5 devices produced at the beginning of 2012.

“PHOTONICA. The world of laser and optics” fair, which is held annually in Expocenter, is the most recognized and competent platform for demonstration of achievements in the field of laser techniques, optics and electro optics. It gathers respectable target audience, including not only technical specialists and professionals, but also consumers and users of the developed equipment. This year the fair presented 149 participating companies from 12 countries (Russia, USA, Germany, France, China, etc.) and was visited by around 8,000 people.

At the fair, technical specialists, who are engaged in laser technologies, as well as practicing general practitioners and dentists got acquainted with stLase and paid attention to its core advantages: compatibility, multifunctionality, usability as well as its relatively low costs. Spheres of application of the equipment, developed by Photonics, are dentistry, non-contact cardiovascular surgery, surgical interference in obstetrics and gynecology, otolaryngology, proctology, and other medical spheres.

Dmitry Popov, managing partner of Maxwell Biotech Venture Fund: “It is really very important for our fund that the product, developed by Photonics, was interesting for  both specialists and potential consumers. As soon as the registration procedures are completed, we are planning to embark on active promotion of stLase to medical equipment marker in Russia and the CIS countries”.

Photo: Photonics stand at PHOTONICA 2012

 

 

Ultra strong bulks and frost resistant cables: which energy effective projects are to become participants of the Skolkovo? Russian skills plus foreign experience: who will open their research laboratories in innovation center? Participants of the Skolkovo concluded an array of contracts during Krasnoyarsk forum. The way a project resident taught the laser some good sense: innovation business is getting on to feet thanks to the fund support.

Watch video

 

Ultra strong bulks and frost resistant cables: which energy effective projects are to become participants of the Skolkovo? Russian skills plus foreign experience: who will open their research laboratories in innovation center? Participants of the Skolkovo concluded an array of contracts during Krasnoyarsk forum. The way a project resident taught the laser some good sense: innovation business is getting on to feet thanks to the fund support.

Watch video

Fear of pain, one can feel in a dental chair, refrains some patients from visiting a dentist. Although modern medical science may make the dental treatment relatively painless, many problems have still not been solved. For a startup company Photonics, that specializes in the development of innovative laser systems for soft and hard tissues surgery, dental clinics are one of the main potential buyers.

Fear of pain, one can feel in a dental chair, refrains some patients from visiting a dentist. Although modern medical science may make the dental treatment relatively painless, many problems have still not been solved. For a startup company Photonics, that specializes in the development of innovative laser systems for soft and hard tissues surgery, dental clinics are one of the main potential buyers. The first product of the company, stLase, designated for operations on soft tissues, will give the dentistry a chance to cure paradontium and oral mucosa disorders and scaling and conduct different surgical interferences effectively and safe. From the very beginning of laser application in medical practice, surgeons have faced a problem of uneven distribution of laser power. Due to the fact that the operated tissues are heterogeneous, a laser ray of the assigned power may “burn through” one areas and not reach the necessary depth in the others.

The human factor inevitably aggravates this effect: uneven movement of laser scalpel in a surgeon’s hand may also lead to heterogeneity of tissue cut. StLase minimizes soft tissues defect in the mouth cavity, as in this case laser is able to correct its own impulse power automatically. If in the past doctors had to define themselves (often by-sight), how long the ray had to operate on these or that areas of the tissues, now the smart device chooses optimal ray power, constantly analyzing temperature in a point that is being affected.  For this to become possible, developers have equipped stLase with a microprocessor, which in real time processes parameters of “feed-back”, which are received via laser and heat channels system.

“A doctor gets a compact laser with the power of 30 watt, any specialist is capable of dealing with easily”, — says Igor Shugailov, the chief medical advisor of Photonics.

The new device interface is not overloaded with any extravagance: only radiation power upper limit and current temperature are reflected during an operation. Although Photonics was registered not long ago, at the end of 2010, the project has been worked upon for several years now involving specialists from different countries.  The device has been tested in Russia and in the USA. Now engineers and doctors continue improving stLase and carrying out clinical trials, expanding the possible application areas of the device.

Dmitry Popov, managing partner of Maxwell Biotech Venture Fund, which is a project investor, itemizes core objectives, set forth before the team: further development of stLase prototype and creation of a series model which will be introduced to the market, drafting operation procedures of production and test performance necessary for the device registration in Russia.

Total investment in Photonics amounts to 40 million rubles. RVC Seed Fund acts as a co-investor.

Following Maxwell Biotech representatives, first small-lot samples of stLase are to appear for their promotion in Russia. Sales will start as soon as Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation issues a registration certificate for the device.

Dmitry Popov anticipates that stLase serial production is to be launched in the second half of 2012.  During the first year the Company is planning to sell some dozens to some hundreds of devices at a price around USD 10 thousand (a quite moderate price for a device with such technical features).

“Later when customers take their time and manage to appreciate the quality and functionality of stLase and all the claimed technologies’ effectiveness is clinically proven, it will become possible to increase the price”, Popov says. 

During the second year of sales the Company is planning to sell the devices for the amount of USD 5-10 mln.  Apart from dentistry, stLase may be used in general surgery, obstetrics and gynecology, otolaryngology, endoscopic and decorative surgery — and this is only the beginning of a long list of profitable areas of its application. However, for the time being the Company is not going to diffuse efforts, but will concentrate on more profitable customers – dental clinics. Key markets stLase is aimed at are Russia, the USA and Europe. Dmitry Popov regrets to recognize, that Russia lags behind the developed countries in terms of the level of penetration of modern medical technologies into everyday practice that is why the company does not expect high demand from domestic medical establishments. Probably, American and European clinics are to apply stLase more actively (whereas prices for the device will be higher than the one set for Russian customers).

February 14, 2012, managers of field-specific departments of Moscow City Executive Board discussed the possibility of application of innovation products and services by the realization of city specialized programs with representatives of small and medium business companies.

OJSC RVC and the Department of Science, industrial policy and entrepreneurship of the city of Moscow acted as initiators of the meeting.

February 14, 2012, managers of field-specific departments of Moscow City Executive Board discussed the possibility of application of innovation products and services by the realization of city specialized programs with representatives of small and medium business companies.

OJSC RVC and the Department of Science, industrial policy and entrepreneurship of the city of Moscow acted as initiators of the meeting.

In the meeting took part Russian companies producing innovation products in the fields of security and terrorism opposition, energy and energy saving, medical information technologies and equipment, information and telecommunication systems. At the 1st meeting RVC introduced such companies as Russian Navigation Technologies, Vokord, Sonda Technology, Aksimed, Bezopasny Internet (Safe Internet), Photonics, Mobix Chip, Light Engines Corporation.

Alexei Chukarin, Advisor of the Head of Department of information technologies of the city of Moscow pointed out that, the project of a Ural company Sonda Technology Shkolnoe Okno which deals with the introduction of biometric security systems for schools and parents alarm systems, was rated as one of TOP-20 IT projects within a Moscow contest – Ideas for Information City. That is why, DIT together with the Department of Education of the City of Moscow is eager to discuss the issues of cooperation with the company, which introduces biometric access control systems in educational establishments. The Department of regional security of the Government of Moscow is also interested in Sonda solutions regarding operative person identification for several seconds. Department representatives consider that Sonda innovation technology may be prospectively used in joint projects of FMS and Moscow Government (Migration Control).

Mobix chip produces unique smart systems for resources accounting (water, gas, electricity, heat supply) which make it possible to read data of consumers and control resources consumption. Following the meeting results Mobix chip representatives are supposed to be included into a working group for the realization of energy saving programs involving departments of science, industrial policy and entrepreneurship, fuel-and-energy economy, municipal housing economy and urban improvement.

AXIMED has presented an innovation medical information system AKSi-clinica, which is able to support the most modern technologies of expansion and support– Cloud Computing and SaaS. Representatives of Moscow office agreed that such development projects may be in demand by the realization of pilot projects of automation of different Moscow MPI, particularly for large multi-purpose day-and-night clinics.

During the meeting RVC suggested Moscow Government support in the field of expertise and innovation production and services.

“It is often not clear for small companies how they may tell officials of Moscow Government that they (these small companies) have introduced this or that product or service, which could be useful for the city, into the market, – Evgeny Kuznetsov, the director of the Department of Development and Communication of OJSC RVC, pointed out. – We suggest arrangement of regular data exchange which makes it possible to identify which demands Moscow Governments has in terms of decisions for the city, and which decisions may be suggested by Russian small and medium business enterprises within capital “innovation order”, as well as use experience of RVC and accredited experts’ network for projects evaluation”.

“Moscow Government is to discuss innovation order realization mechanism with regard to expert possibilities of RVC, - Alexey Komissarov, the Head of Moscow Department of Science, Industrial Policy and Entrepreneurship reported. – Now innovation production of Russian small and medium business companies may be used in pilot projects, for instance, “smart road”, where brand new technologies of Russian companies are to be applied on small areas of the city”.

All companies, represented at the meeting, agreed to take part in pilot projects. Meeting participants came to an agreement to proceed with cooperation. It is supposed to develop mechanisms of cooperation of manufacturers of innovation products and specialized departments of Moscow Government by March 2012.  The generated suggestions will be directed to Sergey Sobyanin, the Moscow Mayor, by the Department of Science, Industrial Policy and Entrepreneurship of the city of Moscow.

Department of science, industrial policy and entrepreneurship of the city of Moscow, February 15, 2012.

Watch video

Supported by innovation center Skolkovo, modern samples of all possible kinds of equipment are being created; a laser device, that can help to treat teeth without a drilling machine and perform complicated surgical operations on soft tissues, is undergoing medical tests in Russia. Kirill Legler has got acquainted with the product.

Watch video

Supported by innovation center Skolkovo, modern samples of all possible kinds of equipment are being created; a laser device, that can help to treat teeth without a drilling machine and perform complicated surgical operations on soft tissues, is undergoing medical tests in Russia. Kirill Legler has got acquainted with the product.

Smile, it won’t hurt! Even the most perfect and the most modern drilling machine will always remain a simple drilling machine in minds of millions of people.  It is not so easy to get over the fear. It is an absolutely different story if a dentist holds no drill in their hand, but instead of it – a laser ray. According to the dentists, patients have the following feelings: it blows a little, some water is sprayed and some clicks can be heard. And this is it!

Laser equipment in medical science is of course no novelty. However, such equipment used to be huge and very expensive for a long time.

Igor Shugailov, Head of Dentistry Department of Russian Medical Academy of Postgraduate Education:

- I remember being a first year student, it was a long time ago, I saw the first laser, which occupied a room of 20 m2. In order to develop laser technologies the first attempts of interference were made on hard tissues of teeth of rats.

Now in Russia a new generation device is being tested. The developers assure, it costs a way cheaper that its predecessors. If one just changes a head piece, one may operate on both soft and hard tissues. Soft tissues, for example, may be cut with no scars left behind thanks to the electric feedback system responsible for this.

Dmitry Popov, managing partner of Maxwell Biotech Venture Fund:

- An additional head piece to the laser for soft tissues surgery is being developed on the basis of diode pumping technology. The created erbioradiation effect will allow to cut hard tissues.

Laser device was created thanks to joint efforts of physicists and medical doctors from Russia and the USA.

Igor Shugailov, Head of Dentistry Department of Russian Medical Academy of Postgraduate Education:

- The device has great power. It is a 30-watt diode laser which can help to perform any surgical interference. This model is designed for dentistry operations. But it may also be applied for any other surgical interference in other medical spheres – in general surgery, urology, cosmetology and ORT-surgery, etc.

Clinical trials will be finished soon. In case of the positive results, the Company will start series production of the device.

Watch video

Authors – Kirill Legler, Danil Gimalov. TV Center.

Photonics, a biotech company invested by Maxwell Biotech Venture Fund and RVC Seed Fund at the beginning of 2011, preceded to the last stage of construction of stLase,  laser device soft tissues surgery. A new ergonomic engineering prototype has been developed and tested by doctors and industry professionals. Technical and price characteristics of the device have been approved. The device is ranged as the best product in the category of laser equipment for soft tissues surgery. Pilot series is planned to be issued at the end of 2011 – beginning of 2012.

Photonics, a biotech company invested by Maxwell Biotech Venture Fund and RVC Seed Fund at the beginning of 2011, preceded to the last stage of construction of stLase,  laser device soft tissues surgery. A new ergonomic engineering prototype has been developed and tested by doctors and industry professionals. Technical and price characteristics of the device have been approved. The device is ranged as the best product in the category of laser equipment for soft tissues surgery. Pilot series is planned to be issued at the end of 2011 – beginning of 2012.

Yan Ryazantsev, the director of the department of investments and expertise of OJSC RVC: “In this project the investments of RVC Seed Fund and a private investor help not only prepare the company for the following investment rounds, but also to finalize the technology and expand the device’s application area. The project team, located in Russia and the US, is working dynamically and productively. I am sure that the obtained unique result is a perfect base for the formation of a substantive portfolio of intellectual property and Photonics’ capitalization growth”.

StLase preclinical trials, completed at the beginning of 2011, proved the possibility of key technologies realization: tissue coagulation effect of stLase through the application of laser-induced heat radiation and laser power automatic control enabling to perform soft tissues surgery with a new level of effectiveness and safety for the first time. In comparison with the existing devices, stLase demonstrates a greater power of laser cut with a more optimal coagulation level, which provides minimal recovery period with no scars. StLase made it possible to discover a new thermo-acousto optic effect. During the research of this effect, a possibility of scaling in the mode of shock wave regeneration and cavitating consequent on thermo-acousto optic effect, has been also demonstrated. This effect together with LPM technology is supposed to be applied for paradontium disorders treatment.

The Company demonstrated preliminary results of the first stage of clinic research of the new method of paradontium disorders treatment based on gum regeneration using LPM and stLase technologies. The turned out to be substantially better than target values: in areas, treated in accordance with LPM technology, abnormal dental pocket depth was reduced by 1 mm. The same technology helped to discover and approbate a new method of highly effective and safe gums hyperpigmentation treatment for the first time in clinical practice.

Thus, research has proven that stLase is able to reach CO2 laser surgery level (gold standard in modern surgery), but in contact regime and at a lower cost. Successful initial stLase application testing for core dental procedures let the leading dentists of the USA and Russia prove advantages of stLase over the existing laser systems.

Igor Shugailov, doctor of medical science, professor, the Head of Dentistry Department of Russian Medical Academy of Postgraduate Education of Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation, the chairman of Russian Laser Dentistry Association: “The developers managed to satisfy one of the most important requirements to surgical laser technologies – increase of ablation speed along with thermal tissue damage decrease. It is achieved thanks to the radiation parameters automatic control system, which was realized for the first time, unique thermo-optical and thermo-acousto optic tips. stLase – is a unique compact powerful laser, that can be used to conduct not only existing but also new methods of operative interference on soft tissues of maxillofacial area”.

Kenneth S. Magid, doctor of dental surgery, assistant professor and director of laser program of a dentistry faculty of York University (New York, the USA): “stLase – is the first laser, that allows to conduct dental procedures with the level of speed, accuracy and control unavailable to the existing diode lasers”.

Report, prepared by recognized opinion leaders of the branch, one more time testifies to the fact that stLase is truly positioned as a premium product with cutting abilities, identical to that of CO2 lasers, and higher control factors of the device and ergonomics than that of competitors. Within the nearest months cooperation with these and other specialists will proceed, which will make it possible to optimize clinical protocols of stLase and create a training program of getting the product ready for introduction into the market the best in its class. Recently obtained preliminary results have already resulted in the interest of two largest dentistry equipment production companies for the project.

As for the development progress of another laser device atLase, designated for hard tissues surgery, Photonics has investigated the influence of atLase prototype on hard tissues and discovered a possibility of texturing and ceramization of enamel surface and dentin for maximum cavity protection.

Let us recall, that at the end of June Photonics passed the expertise of Skolkovo Foundation and was granted a status of Innovation Center Biomedical Cluster resident.

The first ceremony, dedicated for granting a status of an Innovation Center Skolkovo resident, was held on the 4th of July in press-center RIA Novosti. Biotechnological Company Maxwell Photonics joined the biomedical cluster. It is the third portfolio company of Maxwell Biotech Group, which was listed as a participant of Skolkovo Fund.

The first ceremony, dedicated for granting a status of an Innovation Center Skolkovo resident, was held on the 4th of July in press-center RIA Novosti. Biotechnological Company Maxwell Photonics joined the biomedical cluster. It is the third portfolio company of Maxwell Biotech Group, which was listed as a participant of Skolkovo Fund.

Maxwell Photonics is a Russian innovation company, which has been invested by Maxwell Biotech Venture Fund, created with the participation of Russian venture Company and deals with the development and planning of the production and introduction into the Russian market of brand new medical laser systems for soft and hard tissues surgery. Core application area of Maxwell Photonics equipment is dentistry. The equipment has a potential to be used also in surgical interferences in obstetrics and gynecology, otolaryngology, proctology and other medical spheres. RVC Seed Fund is a co-investor of Maxwell Photonics.

Maxwell Photonics, a member of Maxwell Biotech Group, deals with the development and production of the innovative equipment in close partnership with international companies Dental Photonics and Laser Abrasive Technologies, well-known US developers in the field of medical laser technologies. Core advantages of the new laser systems will be their compatibility, multifunctionality, usability as well as its relatively low costs.

Dmitry Popov, managing partner of Maxwell Biotech Venture Fund, is sure that “the equipment, which is being developed within the project of Maxwell Photonics and involves the best technological decisions for surgical laser systems production, will hold a position on the medical laser devices market. We are very glad that another project of the group has got a positive attitude of Skolkovo Fund experts and has become a resident of the innovation center”.

“Granting a status of Skolkovo Fund resident to Maxwell Photonics is another demonstration of the fact that one of the elements of an “innovation lift” – band RVC Skolkovo – is functioning at a steady pace. It is necessary to point out that preferences, which are granted to Skolkovo residents, may substantially optimize companies’ business-plans and this has a very positive influence both on venture funds projects realization terms, and their portfolio companies capitalization growth. Taking into account a substantial experience of Maxwell Biotech Group partners and competitive advantages, which is provided by Skolkovo, we are convinced in substantial success of portfolio company Maxwell Biotech and RVC Seed Fund,” — commented on the event Yan Ryazantsev, the director of the department of investments and expertise of RVC.

On November 30, in Moscow an investment committee meeting of Maxwell Biotech Venture Fund, managed by Maxwell Asset Management and created as state-private partnership with the participation of Russian Venture Company (RVC) was held. At the meeting the committee approved the substantial terms and conditions of the transaction and the amount of investments into Maxwell Photonics. The approved amount of money to be invested is 40 million rubles.

On November 30, in Moscow an investment committee meeting of Maxwell Biotech Venture Fund, managed by Maxwell Asset Management and created as state-private partnership with the participation of Russian Venture Company (RVC) was held. At the meeting the committee approved the substantial terms and conditions of the transaction and the amount of investments into Maxwell Photonics. The approved amount of money to be invested is 40 million rubles.

Maxwell Photonics – is a Russian innovation company, dealing with the development and planning of production and introduction of brand new medical laser systems for hard and soft tissues surgery into the domestic market. Core application area of Maxwell Photonics equipment is dentistry. The equipment has a potential of application in surgical interferences in obstetrics and gynecology, otolaryngology, proctology and other medical spheres.

The brand new equipment is being developed and produced in a close cooperation with such American companies as Palomar Medical Technologies, Dental Photonics and Laser Abrasive Technologies, world leaders of innovation in the sphere of medical laser technologies.

Core advantages of Maxwell Photonics laser systems will be their compatibility, multifunctionality, usability as well as its relatively low costs.

The equipment is expected to hold a substantial share of Russian medical lasers market, which is evaluated at USD 100 mln.